<DOC>
	<DOCNO>NCT01183182</DOCNO>
	<brief_summary>This study design provide clinical data regard safety clinical effectiveness ActiSight Needle Guidance System assist radiologically guide percutaneous needle biopsy aspiration pulmonary lesion , common procedure .</brief_summary>
	<brief_title>Safety Effectiveness Study Needle Guidance System Lung Biopsies</brief_title>
	<detailed_description>This prospective , single-arm study . At least three center Canada participate study least 4 different experienced staff radiologist perform procedure study . A total forty eight ( 48 ) consecutive subject meet eligibility criterion , schedule clinically indicate CT guide lung biopsy aspiration procedure participate center invite enroll study . To ensure diversity study population , consecutive patient enrol follow group group fully enrol : Lesion size ≥1.0 cm ≤ 1.5 cm : 10 patient ; Lesion size &gt; 1.5 ≤ 3.0 cm : 19 patient ; Lesion size &gt; 3.0 cm : 19 patient . A maximum 24 patient enrol center . Informed consent sign prior procedure . Subject data collection day procedure include demographic , relevant medical history vital sign . Enrolled subject undergo CT guide percutaneous lung aspiration and/or biopsy clinically indicate qualified physician , utilize ActiSight Needle Guidance System . Subjects followed-up outlined assess adverse event related procedure . A subject 's enrollment study complete follow-up visit resolution procedure relate adverse event . A procedure difficulty classification define study , base exist literature . Difficulty level procedure record include final report .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Male female subject , 18 year age old time enrollment ; Subjects schedule clinically indicate CT guide percutaneous lung aspiration/biopsy ; Written inform consent participate study ; Ability comply requirement study procedure ; Verified home address phone number facilitate study followup . Significant coagulopathy adequately correct ; Subjects participate active stage drug , intervention treatment trial within 30 day enrollment ; Subjects preexisting condition , opinion investigator , interfere conduct study ; Subjects uncooperative follow instruction ; Mental impairment may preclude completion study procedure ; Pregnant nursing female subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Lung nodule</keyword>
	<keyword>Lung lesion</keyword>
</DOC>